This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: The Innovative Contributions of Ruosen Xie
Introduction
Ruosen Xie is a notable inventor based in Madison, WI (US). He has made significant strides in the field of nanotechnology, particularly in the development of delivery systems for ribonucleoproteins. His work is characterized by a commitment to advancing medical and biotechnological applications.
Latest Patents
Ruosen Xie holds a patent for a "Nanocapsule delivery system for ribonucleoproteins." This innovative patent describes nanocapsules that consist of a single ribonucleoprotein (RNP) complex as a core, encapsulated by a biodegradable crosslinked polymer shell. The RNP complex includes a Cas9 polypeptide and a guide RNA, while the shell is made from polymerized monomers of imidazolyl acryloyl monomers and bisacryloyl disulfide monomers, among other components. This invention also outlines methods for creating the nanocapsules, kits that contain them, and techniques for delivering the encapsulated RNP to cells.
Career Highlights
Ruosen Xie is associated with the Wisconsin Alumni Research Foundation, where he continues to contribute to groundbreaking research and development. His work has garnered attention for its potential applications in gene editing and therapeutic delivery systems.
Collaborations
Ruosen has collaborated with esteemed colleagues such as Shaoqin Gong and Amr Ashraf Abdeen. These partnerships have further enriched his research and expanded the impact of his innovations.
Conclusion
Ruosen Xie's contributions to the field of nanotechnology and his innovative patent for a nanocapsule delivery system highlight his role as a leading inventor. His work promises to advance the capabilities of medical treatments and biotechnological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
